The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The feasibility of an educational and monitoring smartphone application for patients with advanced renal cell carcinoma undergoing combination immunotherapy.
 
Gabriel Roman Souza
No Relationships to Disclose
 
Mahati Paravathaneni
No Relationships to Disclose
 
Filip Ionescu
No Relationships to Disclose
 
Keerthi Gullapalli
No Relationships to Disclose
 
Sarah Raymond
Honoraria - Total Health Conferencing
 
Ghazal Jameel
Employment - Moffitt Cancer Center
Consulting or Advisory Role - AVEO
Speakers' Bureau - AVEO; Genzyme
 
Juskaran Chadha
No Relationships to Disclose
 
Rohit K. Jain
Honoraria - Curio Science; DAVA Oncology; FLASCO; MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Sanofi
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb; Gilead Sciences; NCI
Travel, Accommodations, Expenses - DAVA Oncology; FLASCO; Sanofi
 
Gillian Trujillo
No Relationships to Disclose
 
Amayla M. Budet DeJesus
No Relationships to Disclose
 
Brandon J. Manley
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - EGFR splice variant as a biomarker in renal cancer (Inst)
 
Amy Schneider
No Relationships to Disclose
 
Youngchul Kim
No Relationships to Disclose
 
Adele Semaan
No Relationships to Disclose
 
Heather S.L. Jim
Consulting or Advisory Role - Janssen Medical Affairs; Merck
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Methods of Treating Cognitive Impairment, United States Letters Patent No. 10806772, 10/20/2020
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN; President of Global Society of Rare GU Tumors; Société Internationale d’Urologie Journal
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Exelixis; Pfizer